ストックスクリーナーアプリを入手
2.00
6.10%
-0.13
アフターアワーズ：
2.00
前日終値:
$2.13
開ける：
$2.12
24時間の取引高:
348.36K
Relative Volume:
1.07
時価総額：
$233.70M
収益：
-
当期純損益:
$-13.73M
株価収益率:
-15.38
EPS:
-0.13
ネットキャッシュフロー:
$-3.92M
1週間 パフォーマンス:
-4.31%
1か月 パフォーマンス:
+35.14%
6か月 パフォーマンス:
+152.53%
1年 パフォーマンス:
+83.49%
1日の値動き範囲:
$1.90
$2.1399
1週間の範囲:
$1.90
$2.53
52週間の値動き範囲:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
TLSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
2.00 | 248.89M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-12-22 | 開始されました | B. Riley Securities | Buy |
| 2018-12-17 | 開始されました | Laidlaw | Buy |
Tiziana Life Sciences Ltd (TLSA) 最新ニュース
Tiziana Life Sciences doses first patient in Phase 2a trial of Foralumab for rare disease - Proactive financial news
Tiziana Life Sciences doses first patient in Phase 2a MSA trial - Proactive Investors
Is Tiziana Life Sciences Ltd stock bottoming out2025 Price Targets & Smart Swing Trading Techniques - Newser
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy - The Manila Times
Novel Intranasal Treatment Begins Trial for Incurable Brain Disorder Affecting 50,000 Americans - Stock Titan
What institutional flow reveals about Tiziana Life Sciences LtdJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - Newser
What makes Tiziana Life Sciences Ltd stock price move sharplyJuly 2025 Setups & Expert Verified Stock Movement Alerts - Newser
Applying sector rotation models to Tiziana Life Sciences LtdJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Will Tiziana Life Sciences Ltd stock benefit from interest rate changesWeekly Stock Recap & Weekly Return Optimization Alerts - Newser
Should you hold or exit Tiziana Life Sciences Ltd nowJuly 2025 Momentum & Consistent Profit Alerts - Newser
Smart tools for monitoring Tiziana Life Sciences Ltd’s price actionPortfolio Value Summary & High Accuracy Trade Signal Alerts - Newser
Can Tiziana Life Sciences Ltd hit a new high this monthCapital Protection Strategy With Risk Analysis - Newser
Analyzing Tiziana Life Sciences Ltd with multi timeframe chartsShort-Term Support and Resistance Forecast - Newser
Top chart patterns to watch in Tiziana Life Sciences LtdBuy/Sell Zone Confirmation Technical Analysis - Newser
Multi factor analysis applied to Tiziana Life Sciences LtdFree Growth Based Stock Signal Screener - Newser
What moving averages say about Tiziana Life Sciences Ltd [Trade Analysis Report]Free Real-Time Buy Signal Notifications - Newser
Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Decreases and Increases - investchronicle.com
Has Tiziana Life Sciences Ltd formed a bullish divergenceEquity Market Return Forecast Model Update - Newser
Tiziana Life’s Phase IIa multiple system atrophy study gets FDA approval - Yahoo Finance
How to interpret RSI for Tiziana Life Sciences Ltd stockPredictable Return Plan with Entry Guidance - Newser
What high frequency data says about ENDRA Life Sciences Inc.Entry and Exit Strategy for Swing Traders - Newser
What analysts say about Tiziana Life Sciences Ltd stock outlookDaily Technical Forecast for Quick Gains - Newser
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy - Informazione.it
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive financial news
Market movers: Micron, Barrick, Tiziana Life Sciences, American Resources... - Proactive financial news
What moving averages say about Tiziana Life Sciences LtdSteady Return Plan Based on Data Analysis - Newser
Tiziana Life Sciences Phase 2a multiple system atrophy study green-lit by FDA - Proactive Investors
Tiziana to begin testing foralumab in multiple system atrophy - Seeking Alpha
Tiziana Life Sciences Announces FDA Approval of IND for Phase 2a Clinical Trial of Intranasal Foralumab in Multiple System Atrophy Patients - Quiver Quantitative
FDA Green-Lights Revolutionary Nasal Spray Treatment for Fatal Brain Disease Multiple System Atrophy - Stock Titan
Tiziana shares climb on FDA nod to test foralumab for multiple system atrophy - Proactive financial news
How to monitor Tiziana Life Sciences Ltd with trend dashboardsValue Holding Return Summary With Outlook - Newser
Detecting support and resistance levels for Tiziana Life Sciences LtdFree Value Investing Picks With Stability - Newser
Why Tiziana Life Sciences Ltd stock attracts strong analyst attentionSteady Return Plan Based on Data Analysis - Newser
Using economic indicators to assess Tiziana Life Sciences Ltd potentialCapital Growth Summary Over Five Years - Newser
Screener Results Flag Tiziana Life Sciences Ltd as OversoldSecure Capital Picks With Upside Potential Tracked - beatles.ru
Tesla: The Robotaxi Revolution Begins In Austin (TLSA) - Seeking Alpha
Is Tiziana Life Sciences Ltd stock a growth or value playFree Breakout Confirmation With Entry Tracker - Newser
Should I hold or sell Tiziana Life Sciences Ltd stock in 2025Consistently outstanding ROI - Jammu Links News
What catalysts could drive Tiziana Life Sciences Ltd stock higher in 2025Powerful profit generation - Jammu Links News
What analysts say about Tiziana Life Sciences Ltd stockFind the best stocks for sustainable growth - Jammu Links News
Is it the right time to buy Tiziana Life Sciences Ltd stockTriple-digit wealth increases - Jammu Links News
How volatile is Tiziana Life Sciences Ltd stock compared to the marketInvest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Tiziana Life Sciences Ltd stockAchieve rapid portfolio growth with expert help - Jammu Links News
What are Tiziana Life Sciences Ltd company’s key revenue driversMarket-beating performance - Jammu Links News
Is Tiziana Life Sciences Ltd stock overvalued or undervaluedGet real-time alerts on top stocks - Jammu Links News
Tiziana Life Sciences Ltd (TLSA) 財務データ
収益
当期純利益
現金流量
EPS
0.11%
1.56%
大文字化:
|
ボリューム (24 時間):